Native Meta creative and exact outbound link observed October 22, 2026. Redirects were followed to the captured public destination. Advertiser claims are source material; activity does not establish performance. No personal, health or payment details were entered.

A treatment offer develops through customer stories, product education, the care process and a clear purchase entry. Compare the creative with the destination and explore the other ads sharing this route.
Selected for its design and offer structure. Ad performance isn’t available in this collection.
Each inclusion gets its own photo (women doing yoga outdoors, a laptop nutrition class, a phone message thread, three friends together), so the support is shown rather than listed. The price lock line is the clearest statement of Brello's pricing promise in the set, spelling out that the price doesn't rise at renewal or if the dose increases. The layout steps down neatly from the headline to the tiles, the price lock, the per-day price and the button.
NSV (non-scale victory) is community shorthand that a newcomer may not know, so the headline speaks only to people already inside the weight-loss conversation. That's fine for a warm audience, but this ad lands on the same page as Brello's broad prospecting ads. Spell it out in the headline or the tile captions for cold audiences, and keep the NSV version for retargeting people who've already visited.
It speaks in the community's own language to people already familiar with it.
Showing each inclusion as a photo makes the support concrete.
It states the pricing promise in full, answering a common worry about prescription costs.
The daily price and button close the frame after the value is shown.
Tirzepatide at about $5.94 a day (if approved), with fine print restating it as $166 a month on a three-month minimum that renews for $499 every 11 weeks.
The ad sends people to tirzepatidewoo.brellohealth.com, a dedicated Tirzepatide offer page rather than the homepage or a quiz, and it's one of 18 Brello ads in the library that point there. The page mirrors this ad more closely than most: the price lock banner at the very top uses nearly the same words (no extra fees, no hikes if your dosage changes, no price increases at renewal), and the plan and purchase entry under What makes Brello different lists the same supports with a photo beside them. The per-day price is the gap, since the hero shows $166 a month and $499 instead, and adding the daily figure under the hero price would finish the match.
Brello's dedicated Tirzepatide offer page opens on a $166 a month special with the three-month plan box, then moves through reviews, treatment education, a four-step care path, inclusions and FAQs. It's where 18 Brello ads in the library land, all static image ads, built on emotional moments, native-style text posts and offer or inclusion lists.
A price lock banner, the vial with a $166 badge, and a plan box with the $499 three-month plan, Trustpilot rating, transfer note and intake explanation, answering what it costs and what happens when you pay.
Trusted by 80,000+ members with a Trustpilot rating and review cards about community, customer service and members' own results, answering whether people like you have done this.
A deeper look inside Tirzepatide, with a short explanation, a list of what studies examine, footnoted sources and a results-may-vary note, answering what the medication is.
A straightforward path to care in four photo steps (select your plan, provider review, ships to your door, ongoing support), answering how the process works.
What makes Brello different, with six inclusions beside a photo and a Take the First Step button, answering what you get beyond the medication.
Six questions on approval, refunds, timelines and replacements, then the study references, disclaimers and plan terms, answering the last practical doubts.
Read the full breakdown of this page
One of 22 Brello Health ads in the Fluid Inspiration Library, captured from the Meta Ad Library on Oct 22, 2026. We record that an ad ran publicly, not how it performed.